Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 29

Results: 15

TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3815, doi. 10.1038/onc.2014.308

By:

Mounir, Z;
Lin, F;
Lin, V G;
Korn, J M;
Yu, Y;
Valdez, R;
Aina, O H;
Buchwalter, G;
Jaffe, A B;
Korpal, M;
Zhu, P;
Brown, M;
Cardiff, R D;
Rocnik, J L;
Yang, Y;
Pagliarini, R

Publication type:

Article

The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3826, doi. 10.1038/onc.2014.309

By:

Prevete, N;
Liotti, F;
Visciano, C;
Marone, G;
Melillo, R M;
de Paulis, A

Publication type:

Article

Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3839, doi. 10.1038/onc.2014.310

By:

Chen, Y;
Zhang, Z;
Yang, K;
Du, J;
Xu, Y;
Liu, S

Publication type:

Article

LKB1 reduces ROS-mediated cell damage via activation of p38.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3848, doi. 10.1038/onc.2014.315

By:

Xu, H-G;
Zhai, Y-X;
Chen, J;
Lu, Y;
Wang, J-W;
Quan, C-S;
Zhao, R-X;
Xiao, X;
He, Q;
Werle, K D;
Kim, H-G;
Lopez, R;
Cui, R;
Liang, J;
Li, Y-L;
Xu, Z-X

Publication type:

Article

How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3751, doi. 10.1038/onc.2014.320

By:

Lincet, H;
Icard, P

Publication type:

Article

Differential roles of STAT3 in the initiation and growth of lung cancer.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3804, doi. 10.1038/onc.2014.318

By:

Zhou, J;
Qu, Z;
Yan, S;
Sun, F;
Whitsett, J A;
Shapiro, S D;
Xiao, G

Publication type:

Article

NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3780, doi. 10.1038/onc.2014.319

By:

Licciardello, M P;
Müllner, M K;
Dürnberger, G;
Kerzendorfer, C;
Boidol, B;
Trefzer, C;
Sdelci, S;
Berg, T;
Penz, T;
Schuster, M;
Bock, C;
Kralovics, R;
Superti-Furga, G;
Colinge, J;
Nijman, S M;
Kubicek, S

Publication type:

Article

Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3770, doi. 10.1038/onc.2014.304

By:

Brun, S N;
Markant, S L;
Esparza, L A;
Garcia, G;
Terry, D;
Huang, J-M;
Pavlyukov, M S;
Li, X-N;
Grant, G A;
Crawford, J R;
Levy, M L;
Conway, E M;
Smith, L H;
Nakano, I;
Berezov, A;
Greene, M I;
Wang, Q;
Wechsler-Reya, R J

Publication type:

Article

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3882, doi. 10.1038/onc.2015.203

By:

Wu, D-W;
Lee, M-C;
Hsu, N-Y;
Wu, T-C;
Wu, J-Y;
Wang, Y-C;
Cheng, Y-W;
Chen, C-Y;
Lee, H

Publication type:

Article

Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3760, doi. 10.1038/onc.2014.292

By:

Andruska, N;
Zheng, X;
Yang, X;
Helferich, W G;
Shapiro, D J

Publication type:

Article

Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3860, doi. 10.1038/onc.2014.317

By:

Erin, N;
Podnos, A;
Tanriover, G;
Duymuş, Ö;
Cote, E;
Khatri, I;
Gorczynski, R M

Publication type:

Article

Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3791, doi. 10.1038/onc.2014.312

By:

Li, M-Y;
Lai, P-L;
Chou, Y-T;
Chi, A-P;
Mi, Y-Z;
Khoo, K-H;
Chang, G-D;
Wu, C-W;
Meng, T-C;
Chen, G-C

Publication type:

Article

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3884, doi. 10.1038/onc.2015.265

By:

Vetter, G;
Saumet, A;
Moes, M;
Vallar, L;
Le Béchec, A;
Laurini, C;
Sabbah, M;
Arar, K;
Theillet, C;
Lecellier, C-H;
Friederich, E

Publication type:

Article

Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3881, doi. 10.1038/onc.2015.204

By:

Garcia, I;
Crowther, A J;
Gama, V;
Miller, C R;
Deshmukh, M;
Gershon, T R

Publication type:

Article

Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells.

Published in:

Oncogene, 2015, v. 34, n. 29, p. 3871, doi. 10.1038/onc.2014.323

By:

Redmond, A M;
Byrne, C;
Bane, F T;
Brown, G D;
Tibbitts, P;
O'Brien, K;
Hill, A D K;
Carroll, J S;
Young, L S

Publication type:

Article